All In Biotech

Drug Trial Radar · NCT02781493

Efficacy of Prucalopride Plus Polyethylene Glycol in Bowel Preparation for Colonoscopy

Last checked: Nov 20, 2026Latest source record: May 27, 2016 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingRandomized with 600 participants. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

600

Planned (sponsor's estimate)

Start

Jun 2016

Primary completion

Mar 2017

Study completion Mar 2017

Sponsor

Lead sponsor
Shandong UniversityAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Binzhou People's Hospital; Tai'an People's Hospital; Linyi People's Hospital
First posted
May 24, 2016

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 70 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Prucalopride based bowel cleansing regimen might be helpful to improve bowel cleansing quality before colonoscopy.

Conditions

  • Prucalopride Plus Polyethylene Glycol in Bowel Preparation for Colonoscopyp

Interventions

  • 2 mg Prucalopride plus 2 L Polyethylene Glycol regimenDrug

    Patients enrolled in the Prucalopride group will recieve 2 mg Linaclotide plus 2 L Polyethylene Glycol regimen before colonoscopy.

  • 2 mg Placebo plus 2 L Polyethylene Glycol regimenDrug

    Patients enrolled in the Placebo group will recieve 2 mg Placebo plus 2 L Polyethylene Glycol regimen before colonoscopy.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Difference of scores rating by Boston Bowel Preparation Scale between 2 groups.Time frame: 9 months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Department of Gastroenterology, Qilu Hospital, Shandong University

    Jinan, Shandong, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.